| UniProt ID | TPC6B_HUMAN | |
|---|---|---|
| UniProt AC | Q86SZ2 | |
| Protein Name | Trafficking protein particle complex subunit 6B | |
| Gene Name | TRAPPC6B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 158 | |
| Subcellular Localization | Golgi apparatus, cis-Golgi network. Endoplasmic reticulum. | |
| Protein Description | May play a role in vesicular transport from endoplasmic reticulum to Golgi.. | |
| Protein Sequence | MADEALFLLLHNEMVSGVYKSAEQGEVENGRCITKLENMGFRVGQGLIERFTKDTARFKDELDIMKFICKDFWTTVFKKQIDNLRTNHQGIYVLQDNKFRLLTQMSAGKQYLEHASKYLAFTCGLIRGGLSNLGIKSIVTAEVSSMPACKFQVMIQKL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 21 | Phosphorylation | MVSGVYKSAEQGEVE HHHCCHHCCCCCCCC | 21.25 | 24114839 | |
| 35 | Acetylation | ENGRCITKLENMGFR CCCEEEEEHHHHCCE | 33.61 | 25953088 | |
| 35 | Ubiquitination | ENGRCITKLENMGFR CCCEEEEEHHHHCCE | 33.61 | 29967540 | |
| 53 | Acetylation | GLIERFTKDTARFKD HHHHHHHCCCHHHHH | 50.82 | 7966137 | |
| 53 | Ubiquitination | GLIERFTKDTARFKD HHHHHHHCCCHHHHH | 50.82 | 29967540 | |
| 70 | Acetylation | DIMKFICKDFWTTVF HHHHHHHHHHHHHHH | 51.66 | 20167786 | |
| 71 | Ubiquitination | IMKFICKDFWTTVFK HHHHHHHHHHHHHHH | 39.65 | 21890473 | |
| 78 | 2-Hydroxyisobutyrylation | DFWTTVFKKQIDNLR HHHHHHHHHHHHHHC | 39.16 | - | |
| 86 (in isoform 2) | Phosphorylation | - | 39.97 | 24043423 | |
| 90 (in isoform 2) | Phosphorylation | - | 12.97 | 24043423 | |
| 94 (in isoform 2) | Phosphorylation | - | 2.73 | 24043423 | |
| 98 | Acetylation | IYVLQDNKFRLLTQM EEEEECCEEEEEHHH | 39.90 | 19608861 | |
| 109 | Ubiquitination | LTQMSAGKQYLEHAS EHHHHHHHHHHHHHH | 35.17 | 23000965 | |
| 109 (in isoform 1) | Ubiquitination | - | 35.17 | 21890473 | |
| 144 | Phosphorylation | SIVTAEVSSMPACKF EEEEEECCCCCCHHH | 16.66 | 24719451 | |
| 145 | Phosphorylation | IVTAEVSSMPACKFQ EEEEECCCCCCHHHH | 33.68 | 28348404 | |
| 157 | Ubiquitination | KFQVMIQKL------ HHHHEEECC------ | 45.28 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TPC6B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TPC6B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TPC6B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TPC10_HUMAN | TRAPPC10 | physical | 21525244 | |
| TPC6A_HUMAN | TRAPPC6A | physical | 21525244 | |
| TPC2L_HUMAN | TRAPPC2L | physical | 21525244 | |
| TPC2A_HUMAN | TRAPPC2 | physical | 21525244 | |
| TPC2B_HUMAN | TRAPPC2 | physical | 21525244 | |
| TPPC3_HUMAN | TRAPPC3 | physical | 21525244 | |
| TPC3L_HUMAN | TRAPPC3L | physical | 21525244 | |
| TPPC3_HUMAN | TRAPPC3 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-98, AND MASS SPECTROMETRY. | |